|
|
News Breaks | | | | September 21, 2012 | | 07:02 EDT |  | VVUS | VIVUS provides update on the review of the Qsiva's MAA
VIVUS announced that based on preliminary feedback from the European Medicines Agency's, or EMA, Committee for Medicinal Products for Human Use, or CHMP, the company expects an opinion recommending against approval of the Marketing Authorization Application, or MAA, for Qsiva -- phentermine/topiramate ER -- for the treatment of obesity. The formal decision from the CHMP is expected following their October 2012 meeting. If a negative recommendation is issued in October, and depending upon the nature of the objections, the company will either resubmit the MAA at a later date or appeal this decision and request a re-examination by the CHMP. Peter Tam, president of VIVUS commented: "We await the official decision and the formal report which should provide us specifics on any additional requirements leading to the approval of Qsiva in Europe. We will work closely with the CHMP to address the Committee's concerns. VIVUS is committed to making this important medication available to obese patients in Europe." | |
|
News For VVUS From The Last 14 Days Check below for free stories on VVUS the last two weeks. |
|
|
| May 14, 2013 | | 10:01 EDT |  | VVUS | On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: AVG Technologies (AVG) downgraded to Neutral from Buy at Goldman... Cigna (CI) downgraded to Hold from Buy at Jefferies... Cree (CREE) downgraded to Neutral from Buy at Sterne Agee... Melco Crown (MPEL) downgraded to Neutral from Buy at UBS... SolarCity (SCTY) downgraded to Neutral from Buy at Roth Capital... KB Home (KBH) downgraded to Market Perform from Outperform at Raymond James... Ryland Group (RYL) downgraded to Underperform from Market Perform at Raymond James... Alere (ALR) downgraded to Hold from Buy at Craig-Hallum... Evolution Petroleum (EPM) downgraded to Hold from Buy at MLV Equity... Oil States (OIS) downgraded to Hold from Buy at BB&T... VIVUS (VVUS) downgraded to Neutral from Buy at Lazard Capital. | | | 07:33 EDT | | VVUS | VIVUS downgraded to Neutral from Buy at Lazard Capital
 Subscribe for More Information | | | May 13, 2013 | | 07:41 EDT | | VVUS | VIVUS mails letter to stockholders providing business update
Subscribe for More Information | |
|
|
|
|
|
|
